Comprehensive Mitochondrial Genome Analysis by Massively Parallel Sequencing.

Area of Science:

• Genomics
• Molecular Biology
• Medical Genetics

Background:

• Mitochondrial DNA (mtDNA) disorders are a group of heterogeneous genetic conditions.
• Accurate diagnosis of mtDNA disorders is crucial for effective patient management.
• Current diagnostic methods may have limitations in detecting low-level mutations or deletions.

Purpose of the Study:

• To evaluate the utility of Next-Generation Sequencing (NGS) for comprehensive analysis of the mitochondrial genome.
• To assess the sensitivity and accuracy of NGS in detecting various mtDNA mutations and deletions.
• To establish NGS as a powerful tool for the molecular diagnosis of mtDNA disorders.

Main Methods:

• Massively parallel sequencing (MPS) of the entire 16,569 bp mitochondrial genome.
• High-throughput sequencing data analysis to detect point mutations and deletions.
• Accurate quantification of mtDNA point mutation heteroplasmy and determination of deletion breakpoints.

Main Results:

• NGS generates thousands of reads per nucleotide position, ensuring high data quality.
• The method accurately detects and quantifies mtDNA point mutations and deletions.
• NGS demonstrates high sensitivity for detecting low-level and multiple mtDNA deletions.
• Deletion breakpoints can be precisely determined using this approach.

Conclusions:

• Next-generation sequencing is the most powerful tool currently available for the molecular diagnosis of mtDNA disorders.
• This method enables precise quantification of heteroplasmy and identification of deletion breakpoints.
• NGS significantly advances the diagnostic capabilities for a wide range of mitochondrial diseases.